BioXcel Therapeutics (BTAI) stock price prediction is USD. The BioXcel Therapeutics stock forecast is USD for September. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioXcel Therapeutics, Inc. (BTAI) stock forecast and price target · BTAIBioXcel Therapeutics, Inc. + (+%). At close: September 3 PM. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. BioXcel Therapeutics stock would need to gain ,% to reach $1, According to our BioXcel Therapeutics stock forecast, the price of BioXcel.
BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile. View BioXcel Therapeutics, Inc. BTAI stock quote prices, financial information, real-time forecasts, and company news from CNN. Analyst Consensus. Moderate Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. BTAI Sentiment % Sector Average 69% ; Hedge Fund. Mizuho Adjusts PT on BioXcel Therapeutics to $1 From $4 on Solvency Concerns, Uncertainty; Keeps Neutral Rating · UBS Adjusts Price Target on BioXcel. BIOXCEL THERAPEUTICS INC (BTAI) Price Targets From Analysts ; , 8, $75, $22, $49 ; , 8, $75, $22, $ According to the 5 analysts' twelve-month price targets for BioXcel Therapeutics, the average price target is $ The highest price target for BTAI is $ The average price target is $5 with a high estimate of $7 and a low estimate of $1. Sign in to your SmartPortfolio to see more analyst recommendations. Exchange. NASDAQ-CM ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; 1 Year Target. $ ; Today's High/Low. $/$ Find the latest BioXcel Therapeutics Inc (BTAI) stock forecast, month price target, predictions and analyst recommendations. According to analysts, BTAI price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. future price: according to them, BTAI price has a max estimate of USD and a min estimate of USD. Watch BTAI chart and read a more detailed BioXcel.
BTAI is currently covered by 9 analysts with an average price target of $ This is a potential upside of $ (%) from yesterday's end of day. The analyst firm set a price target for $ expecting BTAI to rise to within 12 months (a possible % upside). 17 analyst firms have reported ratings in. The average one-year price target for BioXcel Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ Earnings and Valuation · Earnings Growth. Earnings for BioXcel Therapeutics are expected to grow in the coming year, from ($) to ($) per share. · Price to. According to 4 Wall Street analysts that have issued a 1 year BTAI price target, the average BTAI price target is $, with the highest BTAI stock price. BioXcel Therapeutics Stock Forecast, BTAI stock price prediction. Price target in 14 days: USD. The best long-term & short-term BioXcel Therapeutics. The average price target for BioXcel Therapeutics, Inc. (BTAI) is $ The current on short-term price targets is based on 2 reports. What is BioXcel. BioXcel Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BTAI updated stock price target summary. Stock Price Forecast. The 4 analysts with month price forecasts for BTAI stock have an average target of , with a low estimate of and a high.
On Friday 09/06/ the closing price of the BioXcel Therapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 09/06/ BioXcel Therapeutics, Inc Analyst Price Targets. Average. Current. High. View. Wall Street analysts forecast BTAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTAI. BTAI BioXcel Therapeutics, Inc. Wall St. Analysts Ratings & Price Target ; Post-Market: $ + (+%) ; Wall St. Ratings? ; Strong Buy:2 ; Buy:1 ; Hold. According to 5 analysts, the average rating for BTAI stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the.
Price Target ; NVDA. NVIDIA. ; NIPG. NIP Group. ; TSLA. Tesla. ; AMD. Advanced Micro Devices. ; AAPL. Apple. Strong Buy = 5; Moderate Buy = 4; Hold = 3; Moderate Sell = 2; Strong Sell = 1. Ratings Breakdown. 3 Mths Ago. Moderate Buy. Based on 6 analysts. Chart. See BTAI stock price and Buy/Sell BioXcel Therapeutics. Discuss news and analysts' price predictions with the investor community. Start investingTrade BioXcel. 6 Wall Street analysts have issued ratings. Currently, 3 analysts rated BTAI as Bullish, 0 rated it Bearish, and 3 rated it Neutral. This suggests a possible.